- Home
- HOTH vs GTIM Comparison
HOTH vs GTIM Comparison
Compare HOTH & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- GTIM
- Stock Information
- Founded
- HOTH 2017
- GTIM 1987
- Country
- HOTH United States
- GTIM United States
- Employees
- HOTH N/A
- GTIM N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- GTIM Restaurants
- Sector
- HOTH Health Care
- GTIM Consumer Discretionary
- Exchange
- HOTH Nasdaq
- GTIM Nasdaq
- Market Cap
- HOTH 15.6M
- GTIM 17.1M
- IPO Year
- HOTH 2019
- GTIM 1990
- Fundamental
- Price
- HOTH $1.29
- GTIM $1.73
- Analyst Decision
- HOTH Strong Buy
- GTIM
- Analyst Count
- HOTH 3
- GTIM 0
- Target Price
- HOTH $4.00
- GTIM N/A
- AVG Volume (30 Days)
- HOTH 230.9K
- GTIM 34.5K
- Earning Date
- HOTH 08-12-2025
- GTIM 08-07-2025
- Dividend Yield
- HOTH N/A
- GTIM N/A
- EPS Growth
- HOTH N/A
- GTIM 17.03
- EPS
- HOTH N/A
- GTIM 0.12
- Revenue
- HOTH N/A
- GTIM $143,398,000.00
- Revenue This Year
- HOTH N/A
- GTIM N/A
- Revenue Next Year
- HOTH N/A
- GTIM N/A
- P/E Ratio
- HOTH N/A
- GTIM $15.40
- Revenue Growth
- HOTH N/A
- GTIM 1.78
- 52 Week Low
- HOTH $0.65
- GTIM $1.34
- 52 Week High
- HOTH $3.80
- GTIM $3.45
- Technical
- Relative Strength Index (RSI)
- HOTH 50.80
- GTIM 59.37
- Support Level
- HOTH $1.22
- GTIM $1.69
- Resistance Level
- HOTH $1.31
- GTIM $1.84
- Average True Range (ATR)
- HOTH 0.08
- GTIM 0.10
- MACD
- HOTH -0.00
- GTIM 0.03
- Stochastic Oscillator
- HOTH 57.69
- GTIM 78.00
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.